Erratum: Management of patients with advanced prostate cancer: Recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

S. Gillessen; A. Omlin; G. Attard; J. S. de Bono; E. Efstathiou; K. Fizazi; S. Halabi; P. S. Nelson; O. Sartor; M. R. Smith; H. R. Soule; H. Akaza; T. M. Beer; H. Beltran; A. M. Chinnaiyan; G. Daugaard; I. D. Davis; M. De Santis; C. G. Drake; R. A. Eeles; S. Fanti; M. E. Gleave; A. Heidenreich; M. Hussain; N. D. James; F. E. Lecouvet; C. J. Logothetis; K. Mastris; S. Nilsson; W. K. Oh; D. Olmos; A. R. Padhani; C. Parker; M. A. Rubin; J. A. Schalken; H. I. Scher; A. Sella; N. D. Shore; E. J. Small; C. N. Sternberg; H. Suzuki; C. J. Sweeney; I. F. Tannock; B. Tombal

doi:10.1093/annonc/mdw180

Erratum: Management of patients with advanced prostate cancer: Recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

S. Gillessen, A. Omlin, G. Attard, J. S. de Bono, E. Efstathiou, K. Fizazi, S. Halabi, P. S. Nelson, O. Sartor, M. R. Smith, H. R. Soule, H. Akaza, T. M. Beer, H. Beltran, A. M. Chinnaiyan, G. Daugaard, I. D. Davis, M. De Santis, C. G. Drake, R. A. EelesS. Fanti, M. E. Gleave, A. Heidenreich, M. Hussain, N. D. James, F. E. Lecouvet, C. J. Logothetis, K. Mastris, S. Nilsson, W. K. Oh, D. Olmos, A. R. Padhani, C. Parker, M. A. Rubin, J. A. Schalken, H. I. Scher, A. Sella, N. D. Shore, E. J. Small, C. N. Sternberg, H. Suzuki, C. J. Sweeney, I. F. Tannock, B. Tombal

Eastern Health Clinical School Research

Research output: Contribution to journal › Comment / Debate › Other › peer-review

9 Citations (Scopus)

Abstract

(Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257)) Ann Oncol 2015; 26: 1589–1604 (doi: 10.1093/annonc/mdv257) The funding note for this publication was incomplete; the full funding note should read as follows: funding We gratefully acknowledge the financial support of the following non-profit organisations for the Advanced Prostate Cancer Consensus Conference (APCCC): Cantonal Hospital St Gallen, City and Canton of St Gallen, Swiss Cancer Research Organisation, European School of Oncology (ESO), Swiss Cancer League, the Swiss Oncology Research Network SAKK, Swiss Cancer Foundation, Prostate Cancer Foundation (PCF) and the Günter and Regine Kelm Foundation. We thank the Movember Foundation for the sponsoring of the travel grants (no grant number). We also acknowledge sponsorship from several different for-profit organisations including Abbvie, Amgen, Astellas, AstraZeneca, Bayer Health Care, Bucherer, Dendreon, Janssen, Mundipharma, Myriad, Novartis, Roche, Sanofi Oncology, Teva. (Details on the www.apccc.org). These for-profit organisations supported the conference financially but had no input in the scientific content or the publication.

Original language	English
Pages (from-to)	e3
Number of pages	1
Journal	Annals of Oncology
Volume	30
Issue number	12
DOIs	https://doi.org/10.1093/annonc/mdw180
Publication status	Published - Dec 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdw180Licence: CC BY-NC

298426388-oaFinal published version, 64.8 KBLicence: CC BY-NC

Cite this

Gillessen, S., Omlin, A., Attard, G., de Bono, J. S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R., Soule, H. R., Akaza, H., Beer, T. M., Beltran, H., Chinnaiyan, A. M., Daugaard, G., Davis, I. D., De Santis, M., Drake, C. G., ... Tombal, B. (2019). Erratum: Management of patients with advanced prostate cancer: Recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Annals of Oncology, 30(12), e3. https://doi.org/10.1093/annonc/mdw180

@article{40b3918ccf354852bd9a2d2b7385b2b1,

title = "Erratum: Management of patients with advanced prostate cancer: Recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015",

abstract = "(Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257)) Ann Oncol 2015; 26: 1589–1604 (doi: 10.1093/annonc/mdv257) The funding note for this publication was incomplete; the full funding note should read as follows: funding We gratefully acknowledge the financial support of the following non-profit organisations for the Advanced Prostate Cancer Consensus Conference (APCCC): Cantonal Hospital St Gallen, City and Canton of St Gallen, Swiss Cancer Research Organisation, European School of Oncology (ESO), Swiss Cancer League, the Swiss Oncology Research Network SAKK, Swiss Cancer Foundation, Prostate Cancer Foundation (PCF) and the G{\"u}nter and Regine Kelm Foundation. We thank the Movember Foundation for the sponsoring of the travel grants (no grant number). We also acknowledge sponsorship from several different for-profit organisations including Abbvie, Amgen, Astellas, AstraZeneca, Bayer Health Care, Bucherer, Dendreon, Janssen, Mundipharma, Myriad, Novartis, Roche, Sanofi Oncology, Teva. (Details on the www.apccc.org). These for-profit organisations supported the conference financially but had no input in the scientific content or the publication.",

author = "S. Gillessen and A. Omlin and G. Attard and {de Bono}, {J. S.} and E. Efstathiou and K. Fizazi and S. Halabi and Nelson, {P. S.} and O. Sartor and Smith, {M. R.} and Soule, {H. R.} and H. Akaza and Beer, {T. M.} and H. Beltran and Chinnaiyan, {A. M.} and G. Daugaard and Davis, {I. D.} and {De Santis}, M. and Drake, {C. G.} and Eeles, {R. A.} and S. Fanti and Gleave, {M. E.} and A. Heidenreich and M. Hussain and James, {N. D.} and Lecouvet, {F. E.} and Logothetis, {C. J.} and K. Mastris and S. Nilsson and Oh, {W. K.} and D. Olmos and Padhani, {A. R.} and C. Parker and Rubin, {M. A.} and Schalken, {J. A.} and Scher, {H. I.} and A. Sella and Shore, {N. D.} and Small, {E. J.} and Sternberg, {C. N.} and H. Suzuki and Sweeney, {C. J.} and Tannock, {I. F.} and B. Tombal",

year = "2019",

month = dec,

doi = "10.1093/annonc/mdw180",

language = "English",

volume = "30",

pages = "e3",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "12",

}

Gillessen, S, Omlin, A, Attard, G, de Bono, JS, Efstathiou, E, Fizazi, K, Halabi, S, Nelson, PS, Sartor, O, Smith, MR, Soule, HR, Akaza, H, Beer, TM, Beltran, H, Chinnaiyan, AM, Daugaard, G, Davis, ID, De Santis, M, Drake, CG, Eeles, RA, Fanti, S, Gleave, ME, Heidenreich, A, Hussain, M, James, ND, Lecouvet, FE, Logothetis, CJ, Mastris, K, Nilsson, S, Oh, WK, Olmos, D, Padhani, AR, Parker, C, Rubin, MA, Schalken, JA, Scher, HI, Sella, A, Shore, ND, Small, EJ, Sternberg, CN, Suzuki, H, Sweeney, CJ, Tannock, IF & Tombal, B 2019, 'Erratum: Management of patients with advanced prostate cancer: Recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015', Annals of Oncology, vol. 30, no. 12, pp. e3. https://doi.org/10.1093/annonc/mdw180

TY - JOUR

T1 - Erratum: Management of patients with advanced prostate cancer

T2 - Recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

AU - Gillessen, S.

AU - Omlin, A.

AU - Attard, G.

AU - de Bono, J. S.

AU - Efstathiou, E.

AU - Fizazi, K.

AU - Halabi, S.

AU - Nelson, P. S.

AU - Sartor, O.

AU - Smith, M. R.

AU - Soule, H. R.

AU - Akaza, H.

AU - Beer, T. M.

AU - Beltran, H.

AU - Chinnaiyan, A. M.

AU - Daugaard, G.

AU - Davis, I. D.

AU - De Santis, M.

AU - Drake, C. G.

AU - Eeles, R. A.

AU - Fanti, S.

AU - Gleave, M. E.

AU - Heidenreich, A.

AU - Hussain, M.

AU - James, N. D.

AU - Lecouvet, F. E.

AU - Logothetis, C. J.

AU - Mastris, K.

AU - Nilsson, S.

AU - Oh, W. K.

AU - Olmos, D.

AU - Padhani, A. R.

AU - Parker, C.

AU - Rubin, M. A.

AU - Schalken, J. A.

AU - Scher, H. I.

AU - Sella, A.

AU - Shore, N. D.

AU - Small, E. J.

AU - Sternberg, C. N.

AU - Suzuki, H.

AU - Sweeney, C. J.

AU - Tannock, I. F.

AU - Tombal, B.

PY - 2019/12

Y1 - 2019/12

N2 - (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257)) Ann Oncol 2015; 26: 1589–1604 (doi: 10.1093/annonc/mdv257) The funding note for this publication was incomplete; the full funding note should read as follows: funding We gratefully acknowledge the financial support of the following non-profit organisations for the Advanced Prostate Cancer Consensus Conference (APCCC): Cantonal Hospital St Gallen, City and Canton of St Gallen, Swiss Cancer Research Organisation, European School of Oncology (ESO), Swiss Cancer League, the Swiss Oncology Research Network SAKK, Swiss Cancer Foundation, Prostate Cancer Foundation (PCF) and the Günter and Regine Kelm Foundation. We thank the Movember Foundation for the sponsoring of the travel grants (no grant number). We also acknowledge sponsorship from several different for-profit organisations including Abbvie, Amgen, Astellas, AstraZeneca, Bayer Health Care, Bucherer, Dendreon, Janssen, Mundipharma, Myriad, Novartis, Roche, Sanofi Oncology, Teva. (Details on the www.apccc.org). These for-profit organisations supported the conference financially but had no input in the scientific content or the publication.

AB - (Annals of Oncology (2015) 26(8) (1589–1604), (S0923753419318691), (10.1093/annonc/mdv257)) Ann Oncol 2015; 26: 1589–1604 (doi: 10.1093/annonc/mdv257) The funding note for this publication was incomplete; the full funding note should read as follows: funding We gratefully acknowledge the financial support of the following non-profit organisations for the Advanced Prostate Cancer Consensus Conference (APCCC): Cantonal Hospital St Gallen, City and Canton of St Gallen, Swiss Cancer Research Organisation, European School of Oncology (ESO), Swiss Cancer League, the Swiss Oncology Research Network SAKK, Swiss Cancer Foundation, Prostate Cancer Foundation (PCF) and the Günter and Regine Kelm Foundation. We thank the Movember Foundation for the sponsoring of the travel grants (no grant number). We also acknowledge sponsorship from several different for-profit organisations including Abbvie, Amgen, Astellas, AstraZeneca, Bayer Health Care, Bucherer, Dendreon, Janssen, Mundipharma, Myriad, Novartis, Roche, Sanofi Oncology, Teva. (Details on the www.apccc.org). These for-profit organisations supported the conference financially but had no input in the scientific content or the publication.

UR - http://www.scopus.com/inward/record.url?scp=85079008198&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdw180

DO - 10.1093/annonc/mdw180

M3 - Comment / Debate

C2 - 32041688

AN - SCOPUS:85079008198

VL - 30

SP - e3

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 12

ER -

Erratum: Management of patients with advanced prostate cancer: Recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

Abstract

UN SDGs

Access to Document

Other files and links

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

Cite this